Warfarin Pharmacogenetics: does more accurate dosing benefit patients?

por Eby, Charles
Publicado en Semin Thromb Hemost (2012)

Association between the HLA-DRB1*03:01-DQB1*02:01 haplotype and PF4/heparin antibodies

por Zhang, Ray, Duffy, Brian F., Lange, Vinzenz, Eby, Charles S., Liu, Chang
Publicado en Blood Adv (2019)

Safety concerns related to use of unapproved needles for accessing implantable venous access devices

por Powers, Michelle L. E., Lublin, Douglas, Eby, Charles, Leitman, Susan F., Dynis, Marian, Despotis, George J.
Publicado 2009

Interactive Modeling for Ongoing Utility of Pharmacogenetic Diagnostic Testing: Application for Warfarin Therapy

por Linder, Mark W., Homme, Marjorie Bon, Reynolds, Kristen K., Gage, Brian F., Eby, Charles, Silvestrov, Natalia, Valdes, Roland
Publicado 2009

Gamma-glutamyl carboxylase and its influence on warfarin dose

por King, Cristi R., Deych, Elena, Milligan, Paul, Eby, Charles, Lenzini, Petra, Grice, Gloria, Porche-Sorbet, Rhonda M., Ridker, Paul M., Gage, Brian F.
Publicado 2010

A Randomized Phase II Trial Investigating the Effect of Platelet Function Inhibition on Circulating Tumor Cells in Patients With Metastatic Breast Cancer

por Roop, Ryan P., Naughton, Michael J., Van Poznak, Catherine, Schneider, Jochen G., Lammers, Philip E., Pluard, Timothy J., Johnson, Farley, Eby, Charles S., Weilbaecher, Katherine N.
Publicado 2013

Ability of VKORC1 and CYP2C9 to Predict Therapeutic Warfarin Dose During the Initial Weeks of Therapy

por Ferder, Nicholas, Eby, Charles S., Deych, Elena, Harris, Jenine K., Ridker, Paul M., Milligan, Paul, Goldhaber, Samuel Z., King, Cristi R., Giri, Tusar, McLeod, Howard L., Glynn, Robert J., Gage, Brian F.
Publicado 2009

Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients

por Bass, Anne R., Szymonifka, Jackie D., Rondina, Matthew T., Bogardus, Margaret, Scott, Mitchell G., Woller, Scott C., Stevens, Scott M., Eby, Charles, Merritt, Kerri, Valle, Alejandro Gonzalez Della, Moskowitz, Gerard, Flores, Eva, Gage, Brian F.
Publicado en HSS J (2017)

Genetic-based dosing in orthopedic patients beginning warfarin therapy

por Millican, Eric A., Lenzini, Petra A., Milligan, Paul E., Grosso, Leonard, Eby, Charles, Deych, Elena, Grice, Gloria, Clohisy, John C., Barrack, Robert L., Burnett, R. Stephen J., Voora, Deepak, Gatchel, Susan, Tiemeier, Amy, Gage, Brian F.
Publicado 2007

Heartland Virus and Hemophagocytic Lymphohistiocytosis in Immunocompromised Patient, Missouri, USA

por Carlson, Abigail L., Pastula, Daniel M., Lambert, Amy J., Staples, J. Erin, Muehlenbachs, Atis, Turabelidze, George, Eby, Charles S., Keller, Jesse, Hess, Brian, Buller, Richard S., Storch, Gregory A., Byrnes, Kathleen, Dehner, Louis, Kirmani, Nigar, Kuhlmann, F. Matthew
Publicado en Emerg Infect Dis (2018)

Genetics InFormatics Trial (GIFT) of Warfarin to Prevent Deep Vein Thrombosis (DVT): Rationale and Study Design

por Do, Elizabeth J., Lenzini, Petra, Eby, Charles S., Bass, Anne R., McMillin, Gwendolyn A., Stevens, Scott M., Woller, Scott C., Pendleton, Robert C., Anderson, Jeffrey L., Proctor, Pam, Nunley, Ryan M., Davila-Roman, Victor, Gage, Brian F.
Publicado 2011

Laboratory and Clinical Outcomes of Pharmacogenetic vs. Clinical Protocols for Warfarin Initiation in Orthopedic Patients

por Lenzini, Petra A., Grice, Gloria R., Milligan, Paul E., Dowd, Mary Beth, Subherwal, Sumeet, Deych, Elena, Eby, Charles S., King, Cristi R., Porche-Sorbet, Rhonda M., Murphy, Claire V., Marchand, Renee, Millican, Eric A., Barrack, Robert L., Clohisy, John C., Kronquist, Kathryn, Gatchel, Susan K., Gage, Brian F.
Publicado 2008

CYP4F2 genetic variant alters required warfarin dose

por Caldwell, Michael D., Awad, Tarif, Johnson, Julie A., Gage, Brian F., Falkowski, Mat, Gardina, Paul, Hubbard, Jason, Turpaz, Yaron, Langaee, Taimour Y., Eby, Charles, King, Cristi R., Brower, Amy, Schmelzer, John R., Glurich, Ingrid, Vidaillet, Humberto J., Yale, Steven H., Qi Zhang, Kai, Berg, Richard L., Burmester, James K.
Publicado 2008

Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial

por Kimmel, Stephen E., French, Benjamin, Anderson, Jeffrey L., Gage, Brian F., Johnson, Julie A., Rosenberg, Yves D., Geller, Nancy L., Kasner, Scott E., Eby, Charles S., Joo, Jungnam, Caldwell, Michael D., Goldhaber, Samuel Z., Hart, Robert G., Cifelli, Denise, Madigan, Rosemary, Brensinger, Colleen M., Goldberg, Suzanne, Califf, Robert M., Ellenberg, Jonas H.
Publicado en Am Heart J (2013)

Venous Thromboembolic Disease: Clinical Practice Guidelines in Oncology

por Streiff, Michael B., Bockenstedt, Paula L., Cataland, Spero R., Chesney, Carolyn, Eby, Charles, Fanikos, John, Fogarty, Patrick F., Gao, Shuwei, Garcia-Aguilar, Julio, Goldhaber, Samuel Z., Hassoun, Hani, Hendrie, Paul, Holmstrom, Bjorn, Jones, Kimberly A., Kuderer, Nicole, Lee, Jason T., Millenson, Michael M., Neff, Anne T., Ortel, Thomas L., Smith, Judy L., Yee, Gary C., Zakarija, Anaadriana
Publicado 2011

Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial

por Gage, Brian F., Bass, Anne R., Lin, Hannah, Woller, Scott C., Stevens, Scott M., Al-Hammadi, Noor, Li, Juan, Rodríguez, Tomás, Miller, J. Philip, McMillin, Gwendolyn A., Pendleton, Robert C., Jaffer, Amir K., King, Cristi R., Whipple, Brandi DeVore, Porche-Sorbet, Rhonda, Napoli, Lynnae, Merritt, Kerri, Thompson, Anna M., Hyun, Gina, Anderson, Jeffrey L., Hollomon, Wesley, Barrack, Robert L., Nunley, Ryan M., Moskowitz, Gerard, Dávila-Román, Victor, Eby, Charles S.
Publicado en JAMA (2017)

Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Tria...

por Gage, Brian F., Bass, Anne R., Lin, Hannah, Woller, Scott C., Stevens, Scott M., Al-Hammadi, Noor, Anderson, Jeffrey L., Li, Juan, Rodriguez, Tomás, Miller, J. Philip, McMillin, Gwendolyn A., Pendleton, Robert C., Jaffer, Amir K., King, Cristi R., Whipple, Brandi, Porche-Sorbet, Rhonda, Napoli, Lynnae, Merritt, Kerri, Thompson, Anna M., Hyun, Gina, Hollomon, Wesley, Barrack, Robert L., Nunley, Ryan M., Moskowitz, Gerard, Dávila-Román, Victor, Eby, Charles S.
Publicado en JAMA (2019)

Pharmacogenetic Warfarin Dose Refinements Remain Significantly Influenced by Genetic Factors after One Week of Therapy

por Horne, Benjamin D., Lenzini, Petra A., Wadelius, Mia, Jorgensen, Andrea L., Kimmel, Stephen E., Ridker, Paul M., Eriksson, Niclas, Anderson, Jeffrey L., Pirmohamed, Munir, Limdi, Nita A., Pendleton, Robert C., McMillin, Gwendolyn A., Burmester, James K., Kurnik, Daniel, Stein, C. Michael, Caldwell, Michael D., Eby, Charles S., Rane, Anders, Lindh, Jonatan D., Shin, Jae-Gook, Kim, Ho-Sook, Angchaisuksiri, Pantep, Glynn, Robert J., Kronquist, Kathryn E., Carlquist, John F., Grice, Gloria R., Barrack, Robert L., Li, Juan, Gage, Brian F.
Publicado 2011

A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing

por Kimmel, Stephen E., French, Benjamin, Kasner, Scott E., Johnson, Julie A., Anderson, Jeffrey L., Gage, Brian F., Rosenberg, Yves D., Eby, Charles S., Madigan, Rosemary A., McBane, Robert B., Abdel-Rahman, Sherif Z., Stevens, Scott M., Yale, Steven, Mohler, Emile R., Fang, Margaret C., Shah, Vinay, Horenstein, Richard B., Limdi, Nita A., Muldowney, James A.S., Gujral, Jaspal, Delafontaine, Patrice, Desnick, Robert J., Ortel, Thomas L., Billett, Henny H., Pendleton, Robert C., Geller, Nancy L., Halperin, Jonathan L., Goldhaber, Samuel Z., Caldwell, Michael D., Califf, Robert M., Ellenberg, Jonas H.
Publicado 2013